{
    "organizations": [],
    "uuid": "b583a537f2a4be27bf59e3d0d826d11621bd6d96",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-clementia-pharmaceuticals-reports/brief-clementia-pharmaceuticals-reports-qtrly-loss-per-share-of-0-42-idUSFWN1SG0Q6",
    "ord_in_thread": 0,
    "title": "BRIEF-Clementia Pharmaceuticals Reports Qtrly Loss Per Share Of $0.42",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 9 (Reuters) - Clementia Pharmaceuticals Inc:\n* CLEMENTIA REPORTS FIRST QUARTER 2018 OPERATING RESULTS AND PIPELINE UPDATES\n* CLEMENTIA PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.42\n* CLEMENTIA PHARMACEUTICALS INC - AS OF MARCH 31, 2018, CLEMENTIA HAD CASH AND INVESTMENTS OF $131.6 MILLION. Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-09T18:51:00.000+03:00",
    "crawled": "2018-05-10T17:16:09.017+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "clementia",
        "pharmaceutical",
        "inc",
        "clementia",
        "report",
        "first",
        "quarter",
        "operating",
        "result",
        "pipeline",
        "update",
        "clementia",
        "pharmaceutical",
        "inc",
        "qtrly",
        "loss",
        "per",
        "share",
        "clementia",
        "pharmaceutical",
        "inc",
        "march",
        "clementia",
        "cash",
        "investment",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}